{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:11:57Z","timestamp":1782522717383,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7252202"],"award-info":[{"award-number":["7252202"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["25JL008"],"award-info":[{"award-number":["25JL008"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373765"],"award-info":[{"award-number":["82373765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA0919904"],"award-info":[{"award-number":["2024YFA0919904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-028"],"award-info":[{"award-number":["2021-I2M-1-028"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-029"],"award-info":[{"award-number":["2021-I2M-1-029"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118535","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:34:59Z","timestamp":1766734499000},"page":"118535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sinomenine derivative 1f suppresses glioblastoma through inducing both apoptosis mediated by intrinsic pathway and necroptosis mediated by TNF-\u03b1\/NF-\u03baB\/MAPK signaling pathway"],"prefix":"10.1016","volume":"304","author":[{"given":"Bin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-9245","authenticated-orcid":false,"given":"Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6168-3325","authenticated-orcid":false,"given":"Tengfei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118535_bib1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2025.118535_bib2","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noae047","article-title":"CBTRUS statistical report: american brain tumor association & NCI neuro-oncology branch adolescent and young adult primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2025.118535_bib3","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.12786\/bn.2022.15.e24","article-title":"Treatment of adult gliomas: a current update","volume":"15","author":"Lee","year":"2022","journal-title":"Brain Neurorehabil."},{"key":"10.1016\/j.ejmech.2025.118535_bib4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118535_bib5","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3390\/curroncol30020147","article-title":"Temozolomide chronotherapy in glioma: a systematic review","volume":"30","author":"Jia","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ejmech.2025.118535_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118535_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.614419","article-title":"Anti-glioblastoma activity of kaempferol via programmed cell death induction: involvement of autophagy and pyroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.118535_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ddr.22048","article-title":"Kaempferol suppresses glioma progression and synergistically enhances the antitumor activity of gefitinib by inhibiting the EGFR\/SRC\/STAT3 signaling pathway","volume":"84","author":"Zhou","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2025.118535_bib9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/nu13030950","article-title":"Anticancer mechanism of curcumin on human glioblastoma","volume":"13","author":"Wong","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2025.118535_bib10","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1002\/ptr.8007","article-title":"Gastrodin synergistically increases migration of interleukin-13 receptor alpha2 chimeric antigen receptor t cell to the brain against glioblastoma multiforme: a preclinical study","volume":"37","author":"Huang","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2025.118535_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.28626","article-title":"Demethoxycurcumin: a naturally occurring curcumin analogue for treating non-cancerous diseases","volume":"234","author":"Hatamipour","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2025.118535_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.137001","article-title":"Development of quinoa (chenopodium quinoa willd) protein isolate-gum arabic conjugates via ultrasound-assisted wet heating for spice essential oils emulsification: effects on water solubility, bioactivity, and sensory stimulation","volume":"431","author":"Chen","year":"2024","journal-title":"Food Chem."},{"key":"10.1016\/j.ejmech.2025.118535_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123168","article-title":"Chitosan-based buccal mucoadhesive patches to enhance the systemic bioavailability of tizanidine","volume":"642","author":"Arpa","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2025.118535_bib14","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/acs.molpharmaceut.0c00968","article-title":"Development of a prodrug of camptothecin for enhanced treatment of glioblastoma multiforme","volume":"18","author":"Checa-Chavarria","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2025.118535_bib15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41392-023-01666-3","article-title":"The tumor-enriched small molecule gambogic amide suppresses glioma by targeting WDR1-dependent cytoskeleton remodeling","volume":"8","author":"Qu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118535_bib16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11655-019-3151-2","article-title":"Mechanism underlying antitumor effects of sinomenine","volume":"25","author":"Gao","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.ejmech.2025.118535_bib17","doi-asserted-by":"crossref","first-page":"8645","DOI":"10.3390\/molecules27248645","article-title":"Towards better sinomenine-type drugs to treat rheumatoid arthritis: molecular mechanisms and structural modification","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118535_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1876862","article-title":"Analgesic mechanism of sinomenine against chronic pain","volume":"2020","author":"Jiang","year":"2020","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.ejmech.2025.118535_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110227","article-title":"A review on pharmacokinetics of sinomenine and its anti-inflammatory and immunomodulatory effects","volume":"119","author":"Wang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.118535_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1015035","article-title":"Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders","volume":"13","author":"Hong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118535_bib21","article-title":"Sinomenine in cardio-cerebrovascular diseases: potential therapeutic effects and pharmacological evidences","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejmech.2025.118535_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113718","article-title":"Sinomenine-glycyrrhizic acid self-assembly enhanced the anti-inflammatory effect of sinomenine in the treatment of rheumatoid arthritis","volume":"382","author":"Jiang","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2025.118535_bib23","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.02.023","article-title":"Therapeutic effect analysis of sinomenine on rat cerebral ischemia-reperfusion injury","volume":"25","author":"Yang","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ejmech.2025.118535_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12974-016-0739-8","article-title":"Sinomenine activates astrocytic dopamine d2 receptors and alleviates neuroinflammatory injury via the CRYAB\/STAT3 pathway after ischemic stroke in mice","volume":"13","author":"Qiu","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2025.118535_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2019.03.061","article-title":"Sinomenine facilitates the efficacy of gabapentin or ligustrazine hydrochloride in animal models of neuropathic pain","volume":"854","author":"Gao","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118535_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/ijms20010070","article-title":"Research advances and prospects on mechanism of sinomenin on histamine release and the binding to histamine receptors","volume":"20","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118535_bib27","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/j.apsb.2021.05.027","article-title":"Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3k\/AKT\/mTOR and AMPK\/mTOR pathway","volume":"11","author":"Zheng","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118535_bib28","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1111\/bph.17464","article-title":"7 i, a structurally modified sinomenine, exerts dual anti-GBM effects by inhibiting glioblastoma proliferation and inducing necroptosis which further mediates lysosomal cell death","volume":"182","author":"Yang","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118535_bib29","article-title":"Research, development and pharmacological activity of sinomenine and its derivatives","author":"Zong","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118535_bib30","first-page":"1141","article-title":"Exploring the molecular mechanism of cinnamic acid-mediated cytotoxicity in triple negative MDA-MB-231 breast cancer cells, anti-cancer agents Med","volume":"21","author":"Pal","year":"2021","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2025.118535_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200052","article-title":"Cinnamic acid hybrids as anticancer agents: a mini-review","volume":"355","author":"Feng","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.118535_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123474","article-title":"A sensitive LC-MS method for the determination of sinomenine derivative SWX and its application to pharmacokinetic research in rats","volume":"1213","author":"Ge","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ejmech.2025.118535_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.biopha.2017.12.065","article-title":"Sinomenine reduces growth and metastasis of breast cancer cells and improves the survival of tumor-bearing mice through suppressing the SHh pathway","volume":"98","author":"Song","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118535_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fcell.2019.00355","article-title":"Mitochondrial involvement in migration, invasion and metastasis","volume":"7","author":"Denisenko","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2025.118535_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s10020-024-00899-4","article-title":"Mitochondria: a new intervention target for tumor invasion and metastasis","volume":"30","author":"Zhou","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejmech.2025.118535_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118535_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113564","article-title":"Design, synthesis and biological evaluation of n-anthraniloyl tryptamine derivatives as pleiotropic molecules for the therapy of malignant glioma","volume":"222","author":"Fan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118535_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.118535_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118535_bib40","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","article-title":"Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis","volume":"575","author":"Fritsch","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118535_bib41","article-title":"RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118535_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082185","article-title":"The role of necroptosis in ROS-mediated cancer therapies and its promising applications","volume":"12","author":"Hsu","year":"2020","journal-title":"Cancers"}],"updated-by":[{"DOI":"10.1016\/j.ejmech.2026.118669","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000}},{"DOI":"10.1016\/j.ejmech.2026.118669","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000}}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425013005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425013005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:32:28Z","timestamp":1773945148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425013005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"alternative-id":["S0223523425013005"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118535","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sinomenine derivative 1f suppresses glioblastoma through inducing both apoptosis mediated by intrinsic pathway and necroptosis mediated by TNF-\u03b1\/NF-\u03baB\/MAPK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118535"}}